Annalisa Bruno

2.2k citations
47 papers · 1.5k indexed · h-index 24

Annalisa Bruno

45 papers receiving 1.5k citations

Peers

Annalisa Bruno
Comparison fields: 5 of 112
  • Pharmacology 559
  • Biochemistry 153
  • Internal Medicine 72
  • Cancer Research 227
  • Oncology 312
Replace Graham P. Pidgeon with:
Graham P. Pidgeon Ireland
Nicholas S. Kirkby United Kingdom
Pier Paolo Gazzaniga Italy
Anders Vik Norway
Maria G. Sciulli Italy
Chang‐Hui Liao Taiwan
Kimiyoshi Ichida Japan
Maurizio Degan Italy
G M Chisolm United States
Aleksandr E. Vendrov United States
Annalisa Bruno relative to Graham P. Pidgeon Ireland Graham P. Pidgeon's profile →
Citations per field
00.5×1.5×2.4×
Graham P. Pidgeon · 1×
Citations per year

Countries citing papers authored by Annalisa Bruno

Since Specialization
Citations

This map shows the geographic impact of Annalisa Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annalisa Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annalisa Bruno more than expected).

Fields of papers citing papers by Annalisa Bruno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annalisa Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annalisa Bruno. The network helps show where Annalisa Bruno may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Annalisa Bruno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Annalisa Bruno Line = papers co-authored together Annalisa Bruno links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202415
2 20240
3 20245
4 20245
5 202316
6 202214
7 202239
8 202220
9 202011
10 202020
11 20204
12 201928
13 201952
14 201850
15 201851
16 2012100
17 201228
18 201050
19 200944
20 2005135

About Annalisa Bruno

Annalisa Bruno is a scholar working on Pharmacology, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (29 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Eicosanoids and Hypertension Pharmacology (11 papers), Cancer, Lipids, and Metabolism (7 papers), Estrogen and related hormone effects (5 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Synthesis of β-Lactam Compounds (4 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Pharmacology (559 citations), Biochemistry (153 citations) and Internal Medicine (72 citations). Annalisa Bruno has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Paola Patrignani, Stefania Tacconelli, Melania Dovizio, Patrizia Ballerini, Annalisa Contursi, Rosalia Grande, Dan A. Dixon, Fernando F. Blanco, Ángel Lanas and Carlos Sostres. Their work appears in journals such as Gastroenterology, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026